Bin Zhang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Top Venues

NPJ precision oncology

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Han Gong, Peihe Zhang, Qiang Liu, Yuxuan Tian, Fuxin Chen, Siyi Qian, Chaofeng Tu, Yue-Qiu Tan, Xingming Hu, Bin Zhang
XRCC2 driven homologous recombination subtypes and therapeutic targeting in lung adenocarcinoma metastasis. NPJ precision oncology 8 (1) (2024)
Han Gong, Peihe Zhang, Qiang Liu, Yuxuan Tian, Fuxin Chen, Siyi Qian, Chaofeng Tu, Yue-Qiu Tan, Xingming Hu, Bin Zhang
XRCC2 driven homologous recombination subtypes and therapeutic targeting in lung adenocarcinoma metastasis. NPJ precision oncology 8 (1) (2024)
Han Gong, Peihe Zhang, Qiang Liu, Yuxuan Tian, Fuxin Chen, Siyi Qian, Chaofeng Tu, Yue-Qiu Tan, Xingming Hu, Bin Zhang
XRCC2 driven homologous recombination subtypes and therapeutic targeting in lung adenocarcinoma metastasis. NPJ precision oncology 8 (1) (2024)
Yiting Chen, Xueping Feng, Yuhao Yuan, Jiahui Jiang, Peihe Zhang, Bin Zhang
Identification of a novel mechanism for reversal of doxorubicin-induced chemotherapy resistance by TXNIP in triple-negative breast cancer via promoting reactive oxygen-mediated DNA damage. Cell death & disease 13 (4) (2022)
Hui Li, Mridul Roy, Long Liang, Wenjie Cao, Bin Hu, Yanan Li, Xiaojuan Xiao, Haiqin Wang, Mao Ye, Shuming Sun, Bin Zhang, Jing Liu
Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multiple myeloma by stabilizing HMGB1. Oncogene 41 (9) (2022)